Rozalyn Levine Rodwin, MD
Assistant Professor
Research & Publications
Biography
News
Coauthors
Selected Publications
- Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932.Balsamo L, Kairalla J, Hibbitts E, Rodwin R, Devidas M, Dreyzin A, Winick N, Carroll W, Hunger S, Raetz E, Schore R, Loh M, Ness K, Angiolillo A, Kadan-Lottick N. Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932. Journal Of Clinical Oncology 2023, 41: 10025-10025. DOI: 10.1200/jco.2023.41.16_suppl.10025.
- A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapyIbrahim EY, Munshani S, Domenicano I, Rodwin R, Nowak RJ, Pusztai L, Lustberg M, Ehrlich BE. A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy. PLOS ONE 2022, 17: e0275648. PMID: 36206298, PMCID: PMC9543876, DOI: 10.1371/journal.pone.0275648.
- Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case–Control StudyGraham C, Metayer C, Morimoto LM, Wiemels JL, Siddique A, Di M, Rodwin RL, Kadan-Lottick NS, Ma X, Wang R. Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case–Control Study. Cancer Epidemiology Biomarkers & Prevention 2022, 31: 1788-1795. PMID: 35709749, PMCID: PMC9444874, DOI: 10.1158/1055-9965.epi-22-0335.
- Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.Rodwin RL, Kairalla JA, Hibbitts E, Devidas M, Whitley MK, Mohrmann CE, Schore RJ, Raetz E, Winick NJ, Hunger SP, Loh ML, Hockenberry MJ, Angiolillo AL, Ness KK, Kadan-Lottick NS. Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia. Journal Of The National Cancer Institute 2022, 114: 1167-1175. PMID: 35552709, PMCID: PMC9360458, DOI: 10.1093/jnci/djac095.
- Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic LeukemiaRodwin RL, Ma X, Ness KK, Kadan-Lottick NS, Wang R. Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia. JCO Oncology Practice 2022, 18: e1060-e1068. PMID: 35427182, PMCID: PMC9287366, DOI: 10.1200/op.21.00796.
- Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future DirectionsRodwin RL, Siddiq NZ, Ehrlich BE, Lustberg MB. Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. Frontiers In Pain Research 2022, 3: 864910. PMID: 35360655, PMCID: PMC8963873, DOI: 10.3389/fpain.2022.864910.
- Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcomaKadan-Lottick NS, Zheng DJ, Wang M, Bishop MW, Srivastava DK, Ross WL, Rodwin RL, Ness KK, Gibson TM, Spunt SL, Okcu MF, Leisenring WM, Robison LL, Armstrong GT, Krull KR. Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma. Journal Of Cancer Survivorship 2022, 17: 1238-1250. PMID: 35059962, PMCID: PMC9300774, DOI: 10.1007/s11764-021-01154-z.
- Newly identified chemotherapy‐induced peripheral neuropathy in a childhood cancer survivorship clinicRodwin RL, Ross WL, Rotatori J, Allen K, Auerbach C, Balsamo LM, Kadan‐Lottick N. Newly identified chemotherapy‐induced peripheral neuropathy in a childhood cancer survivorship clinic. Pediatric Blood & Cancer 2021, 69: e29550. PMID: 34971076, PMCID: PMC8805800, DOI: 10.1002/pbc.29550.
- Clinical decision rule for obtaining peripheral blood cultures in febrile oncology patientsGorfinkel L, Hansen CE, Teng W, Shabanova V, Prozora S, Rodwin R, Qadri U, Manghi T, Emerson B, Riera A. Clinical decision rule for obtaining peripheral blood cultures in febrile oncology patients. Pediatric Blood & Cancer 2021, 69: e29519. PMID: 34939321, DOI: 10.1002/pbc.29519.
- Physical Therapy Utilization Among Hospitalized Patients with Pediatric Acute Lymphoblastic LeukemiaRodwin R, Ma X, Ness K, Kadan-Lottick N, Wang R. Physical Therapy Utilization Among Hospitalized Patients with Pediatric Acute Lymphoblastic Leukemia. Blood 2021, 138: 4024. DOI: 10.1182/blood-2021-147232.
- A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal RhabdomyosarcomaRodwin RL, Janardan SK, Hofstatter EW, Kadan-Lottick NS. A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma. Journal Of Pediatric Hematology/Oncology 2021, 44: e585-e588. PMID: 35200227, PMCID: PMC8873988, DOI: 10.1097/mph.0000000000002270.
- Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor StudyRodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS. Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiology Biomarkers & Prevention 2021, 30: 1536-1545. PMID: 34099519, PMCID: PMC8523186, DOI: 10.1158/1055-9965.epi-21-0154.
- Peripheral motor and sensory neuropathy in survivors of childhood central nervous system (CNS) tumors in the St. Jude Lifetime (SJLIFE) cohort.Rodwin R, Lu L, Srivastava D, Brinkman T, Krull K, Armstrong G, Khan R, Phillips N, Merchant T, Gajjar A, Robison L, Hudson M, Kadan-Lottick N, Ness K. Peripheral motor and sensory neuropathy in survivors of childhood central nervous system (CNS) tumors in the St. Jude Lifetime (SJLIFE) cohort. Journal Of Clinical Oncology 2020, 38: 10549-10549. DOI: 10.1200/jco.2020.38.15_suppl.10549.
- Neuromuscular dysfunction and associated health/socioeconomic outcomes: A report from the Childhood Cancer Survivor Study (CCSS).Rodwin R, Chen Y, Yasui Y, Leisenring W, Gibson T, Nathan P, Howell R, Krull K, Mohrmann C, Hayashi R, Chow E, Oeffinger K, Armstrong G, Ness K, Kadan-Lottick N. Neuromuscular dysfunction and associated health/socioeconomic outcomes: A report from the Childhood Cancer Survivor Study (CCSS). Journal Of Clinical Oncology 2020, 38: 10546-10546. DOI: 10.1200/jco.2020.38.15_suppl.10546.
- Reduction in Hospital Days Using a Multidisciplinary Approach for Pediatric Patients with Sickle Cell DiseasePashankar F, Rodwin R, Balsamo L, Carbonella J, Szondy M, Kalbfeld K, Thomas D, Santucci K, Grossman M. Reduction in Hospital Days Using a Multidisciplinary Approach for Pediatric Patients with Sickle Cell Disease. Blood 2018, 132: 2240. DOI: 10.1182/blood-2018-99-113595.
- Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009.Lin RY, Levine RJ, Lin H. Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009. Allergy Asthma Proc 2013, 34: 65-71. PMID: 23406938, DOI: 10.2500/aap.2013.34.3618.
- Evolution of end-of-life care at United States hospitals in the new millennium.Lin RY, Levine RJ, Scanlan BC. Evolution of end-of-life care at United States hospitals in the new millennium. J Palliat Med 2012, 15: 592-601. PMID: 22577786, DOI: 10.1089/jpm.2011.0432.